Is CORZ a buy according to UQS?

UQS rates CORZ as Poor at 30.5/100, driven primarily by the Growth pillar at 65.0. Every other pillar — Quality (17.2), Moat (10.0), Risk (29.6), and Valuation (41.4) — scores below 50. The rating reflects a pre-profitability, high-leverage business where the entire thesis rests on forward growth estimates materializing. The Poor label indicates significant fundamental weakness across the majority of the scoring framework.

What is CORZ's PEG ratio and what does it mean?

CORZ carries a PEG ratio of -0.06, which is negative because TTM earnings are negative — making the standard PEG interpretation inapplicable. A negative PEG does not signal cheapness; it reflects that the company is currently unprofitable. The sector median PEG is 1.27. Investors relying on forward metrics should note the forward P/E of 49.6, which prices in substantial earnings recovery that has not yet been demonstrated in reported financials.

Why might CORZ's UQS Score change?

The UQS Score updates daily based on trailing twelve-month financials and forward analyst estimates. For CORZ, the most sensitive inputs are forward revenue and EPS growth estimates — if analysts revise these downward, the Growth pillar (currently the sole strong pillar at 65.0) would decline. Improvements in operating margin, free cash flow, or debt reduction could lift Quality and Risk scores. Score changes of 5 or more points trigger a page regeneration.

CORZ

Technology

Core Scientific, Inc. · Software - Infrastructure · $7B

UQS Score — Balanced Preset

37.2

Below Average

Core Scientific, Inc. scores 37.2/100 using the Balanced preset.

UQS vs Technology Sector

CORZ

37.2

Sector avg

38.0

Quality

Weak

Moat

Weak

Growth

Good

Risk

Neutral

Valuation

Neutral

CORZ Price History

+628.9% over 5Y

Monthly close, adjusted for stock splits and dividend reinvestment.

Return Calculator

What if I invested in Core Scientific, Inc.?

If I had invested

Starting

Today it would be worth

$12,423

That's a +24.2% total return, or +24.2% annualized.

Based on Core Scientific, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.

Unlock Full CORZ Analysis

✓Detailed 6-pillar UQS breakdown with exact scores
✓All 29 metrics with sector-calibrated comparisons
✓6 investor presets (Buffett, Munger, Lynch, Wood, Graham, Balanced)
✓Watchlist tracking with score alerts
✓AI-generated investment perspectives across 6 preset views
✓Score history chart with change notifications

Analyze CORZ in Detail →

Pro Analysis

CORZ — Score History

Score changes· 30/47 most recent

Date	UQS	Quality	Moat	Growth	Risk	Value	Change
Jul 8, 2026	37.2	17.2	10.0	65.0	59.3	56.6	+0.1
Jul 7, 2026	37.1	17.2	10.0	65.0	59.3	56.0	-0.1
Jul 3, 2026	37.2	17.2	10.0	65.0	59.3	56.7	+0.2
Jul 2, 2026	37.0	17.2	10.0	65.0	59.3	55.6	+0.1
Jun 30, 2026	36.9	17.2	10.0	65.0	59.3	54.7	+0.1
Jun 26, 2026	36.8	17.2	10.0	65.0	59.3	54.3	0.0
Jun 25, 2026	36.8	17.2	10.0	65.0	59.3	54.1	0.0
Jun 19, 2026	36.8	17.2	10.0	65.0	59.3	53.7	0.0
Jun 18, 2026	36.8	17.2	10.0	65.0	59.3	53.9	0.0
Jun 16, 2026	36.8	17.2	10.0	65.0	59.3	54.0	0.0

CORZ — Pillar Breakdown

◆

Quality

— 17.2/100 (25%)

Core Scientific, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.

Capital Efficiency (ROIC)Weak

How effectively capital is deployed to generate returns.

Return on EquityStrong

Profitability relative to shareholders' equity.

Operating ProfitabilityWeak

Ability to convert revenue into operating profit.

Net ProfitabilityWeak

Bottom-line profit as a share of revenue.

Gross Profit / AssetsWeak

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationWeak

Free cash flow relative to market value.

▲

Growth

— 65.0/100 (20%)

Core Scientific, Inc. demonstrates healthy growth trends across revenue and earnings.

Recent Revenue TrendWeak

Revenue trajectory over the last twelve months.

3Y Revenue CAGRWeak

Compound annual revenue growth rate over 3 years.

EPS GrowthStrong

Year-over-year earnings per share growth.

Forward Revenue OutlookStrong

Analyst consensus for future revenue growth.

Forward EPS GrowthStrong

Analyst consensus for future earnings growth.

◈

Risk

— 59.3/100 (15%)

Core Scientific, Inc. maintains a reasonable risk profile with manageable debt levels.

Financial LeverageStrong

Debt levels relative to earnings capacity.

Debt/EquityStrong

Total debt relative to shareholder equity.

Current RatioWeak

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

●

Valuation

— 56.6/100 (15%)

Core Scientific, Inc. trades at a reasonable valuation with decent earnings yield and FCF multiples.

Earnings YieldWeak

Inverse of forward P/E — higher yield means cheaper stock.

PEG RatioStrong

P/E relative to earnings growth — lower is more attractive.

⬡

Moat

— 10/100 (25%)

Core Scientific, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for CORZ.

Score Composition

Quality

17.2×25%4.3

Growth

65.0×20%13.0

Risk

59.3×15%8.9

Valuation

56.6×15%8.5

Moat

10.0×25%2.5

Total

37.2Below Average

Financial Data

More Stock Analysis

How is the CORZ UQS Score Calculated?

The UQS (Unified Quality Score) for Core Scientific, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Core Scientific, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Core Scientific, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.